Kim Kwang Yeon, Kim Ju Whi, Lee Kyung Jae, Park Eunhyang, Kang Gyeong Hoon, Choi Young Hun, Kim Woo Sun, Ko Jung Min, Moon Jin Soo, Ko Jae Sung
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Pediatr Gastroenterol Hepatol Nutr. 2017 Dec;20(4):263-267. doi: 10.5223/pghn.2017.20.4.263. Epub 2017 Dec 22.
Patients with lysosomal acid lipase (LAL) deficiency and glycogen storage disease (GSD) demonstrated hepatomegaly and dyslipidemia. In our case, a 6-year-old boy presented with hepatosplenomegaly. At 3 years of age, GSD had been diagnosed by liver biopsy at another hospital. He showed elevated serum liver enzymes and dyslipidemia. Liver biopsy revealed diffuse microvesicular fatty changes in hepatocytes, septal fibrosis and foamy macrophages. Ultrastructural examination demonstrated numerous lysosomes that contained lipid material and intracytoplasmic cholesterol clefts. A dried blood spot test revealed markedly decreased activity of LAL. gene sequencing identified the presence of a novel homozygous mutation (p.Thr177Ile). The patient's elevated liver enzymes and dyslipidemia improved with enzyme replacement therapy. This is the first report of a Korean child with LAL deficiency, and our findings suggest that this condition should be considered in the differential diagnosis of children with hepatosplenomegaly and dyslipidemia.
溶酶体酸性脂肪酶(LAL)缺乏症和糖原贮积病(GSD)患者表现出肝肿大和血脂异常。在我们的病例中,一名6岁男孩出现肝脾肿大。3岁时,另一家医院通过肝活检诊断出GSD。他的血清肝酶升高且血脂异常。肝活检显示肝细胞弥漫性微泡脂肪变性、间隔纤维化和泡沫状巨噬细胞。超微结构检查显示大量含有脂质物质和胞浆内胆固醇裂隙的溶酶体。干血斑试验显示LAL活性明显降低。基因测序确定存在一种新的纯合突变(p.Thr177Ile)。酶替代疗法使患者升高的肝酶和血脂异常得到改善。这是韩国首例LAL缺乏症儿童的报告,我们的研究结果表明,在肝脾肿大和血脂异常儿童的鉴别诊断中应考虑这种疾病。